Hepatitis B virus infection is dependent on cholesterol in the viral envelope

Cellular Microbiology

Volumn 11, Issue 2, 2009, Pages 249-260

  Bremer, Corinna M ^a   Bung, Christiane ^a   Kott, Nicole ^a   Hardt, Martin ^a   Glebe, Dieter ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 [(3,3' BITHIOPHEN 5 YL)METHOXY] N (6,6 DIMETHYL 2 HEPTEN 4 YNYL) N ETHYLBENZYLAMINE; CHOLESTEROL; FILIPIN; METHYL BETA CYCLODEXTRIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VIRUS CHOLESTEROL;

ARTICLE; CELL CULTURE; CELL MEMBRANE; CELL VIABILITY; CHOLESTEROL DEPLETION; CHOLESTEROL SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPLETION; DNA CONTENT; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIVER CELL; PRIORITY JOURNAL; VIRION; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS PARTICLE;

ANIMALS; CELL LINE; CELLS, CULTURED; CHOLESTEROL; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; TUPAIA; VIRION; VIRUS INTERNALIZATION;

HEPATITIS B VIRUS;

EID: 58349122284     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2008.01250.x     Document Type: Article

References (53)

1. Bender, F.C., Whitbeck, J.C., Ponce de Leon, M., Lou, H., Eisenberg, R.J., and Cohen, G.H. (2003) Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry. J Virol 77: 9542-9552.
2. Berting, A., Fischer, C., Schaefer, S., Garten, W., Klenk, H.D., and Gerlich, W.H. (2000) Hemifusion activity of a chimeric influenza virus hemagglutinin with a putative fusion peptide from hepatitis B virus. Virus Res 68: 35-49.
3. Brown, E.L., and Lyles, D.S. (2003) A novel method for analysis of membrane microdomains: Vesicular stomatitis virus glycoprotein microdomains change in size during infection, and those outside of budding sites resemble sites of virus budding. Virology 310: 343-358.
4. Bruss, V., Hagelstein, J., Gerhardt, E., and Galle, P.R. (1996) Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity. Virology 218: 396-399.
5. Campbell, S., Gaus, K., Bittman, R., Jessup, W., Crowe, S., and Mak, J. (2004) The raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated Brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity. J Virol 78: 10556-10565.
6. Clejan, S., and Bittman, R. (1985) Rates of amphotericin B and filipin association with sterols. A study of changes in sterol structure and phospholipid composition of vesicles. J Biol Chem 260: 2884-2889.
7. Codran, A., Royer, C., Jaeck, D., Bastien-Valle, M., Baumert, T.F., Kieny, M.P., et al. (2006) Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis. J Gen Virol 87: 2583-2593.
8. Gavilanes, F., Gonzalez-Ros, J.M., and Peterson, D.L. (1982) Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins. J Biol Chem 257: 7770-7777.
9. Glebe, D. (2006) Attachment sites and neutralising epitopes of hepatitis B virus. Minerva Gastroenterol Dietol 52: 3-21.
10. Glebe, D., and Gerlich, W.H. (2004) Study of the endocytosis and intracellular localization of subviral particles of hepatitis B virus in primary hepatocytes. Methods Mol Med 96: 143-151.
11. Glebe, D., and Urban, S. (2007) Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13: 22-38.
12. Glebe, D., Aliakbari, M., Krass, P., Knoop, E.V., Valerius, K.P., and Gerlich, W.H. (2003) Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J Virol 77: 9511-9521.
13. Glebe, D., Urban, S., Knoop, E.V., Cag, N., Krass, P., Grun, S., et al. (2005) Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology 129: 234-245.
14. Graham, D.R., Chertova, E., Hilburn, J.M., Arthur, L.O., and Hildreth, J.E. (2003) Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: Evidence for virion-associated lipid rafts. J Virol 77: 8237-8248.
15. Greenwood, A.I., Pan, J., Mills, T.T., Nagle, J.F., Epand, R.M., and Tristram-Nagle, S. (2008) CRAC motif peptide of the HIV-1 gp41 protein thins SOPC membranes and interacts with cholesterol. Biochim Biophys Acta 1778: 1120-1130.
16. Gripon, P., Le Seyec, J., Rumin, S., and Guguen-Guillouzo, C. (1995) Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 213: 292-299.
17. Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., et al. (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA 99: 15655-15660.
18. Horie, M., Tsuchiya, Y., Hayashi, M., Iida, Y., Iwasawa, Y., Nagata, Y., et al. (1990) NB-598: A potent competitive inhibitor of squalene epoxidase. J Biol Chem 265: 18075-18078.
19. Huovila, A.P., Eder, A.M., and Fuller, S.D. (1992) Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment. J Cell Biol 118: 1305-1320.
20. Imhoff, H., von Messling, V., Herrler, G., and Haas, L. (2007) Canine distemper virus infection requires cholesterol in the viral envelope. J Virol 81: 4158-4165.
21. Jursch, C.A., Gerlich, W.H., Glebe, D., Schaefer, S., Marie, O., and Thraenhart, O. (2002) Molecular approaches to validate disinfectants against human hepatitis B virus. Med Microbiol Immunol (Berl) 190: 189-197.
22. Köck, J., Nassal, M., MacNelly, S., Baumert, T.F., Blum, H.E., and von Weizsacker, F. (2001) Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J Virol 75: 5084-5089.
23. Ladner, S.K., Otto, M.J., Barker, C.S., Zaifert, K., Wang, G.H., Guo, J.T., et al. (1997) Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: A novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother 41: 1715-1720.
24. Lambert, C., Doring, T., and Prange, R. (2007) Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin. J Virol 81: 9050-9060.
25. Lawrence, J.C., Saslowsky, D.E., Edwardson, J.M., and Henderson, R.M. (2003) Real-time analysis of the effects of cholesterol on lipid raft behavior using atomic force microscopy. Biophys J 84: 1827-1832.
26. Leistner, C.M., Gruen-Bernhard, S., and Glebe, D. (2008) Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell Microbiol 10: 122-133.
27. Lin, Y.L., Shiao, M.S., Mettling, C., and Chou, C.K. (2003) Cholesterol requirement of hepatitis B surface antigen (HBsAg) secretion. Virology 314: 253-260.
28. Lu, X., Xiong, Y., and Silver, J. (2002) Asymmetric requirement for cholesterol in receptor-bearing but not envelope-bearing membranes for fusion mediated by ecotropic murine leukemia virus. J Virol 76: 6701-6709.
29. Mangold, C.M., and Streeck, R.E. (1993) Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J Virol 67: 4588-4597.
30. Marsh, M., and Helenius, A. (2006) Virus entry: Open sesame. Cell 124: 729-740.
31. Matzno, S., Yamauchi, T., Gohda, M., Ishida, N., Katsuura, K., Hanasaki, Y., et al. (1997) Inhibition of cholesterol biosynthesis by squalene epoxidase inhibitor avoids apoptotic cell death in L6 myoblasts. J Lipid Res 38: 1639-1648.
32. van Meer, G., Voelker, D.R., and Feigenson, G.W. (2008) Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9: 112-124.
33. Nguyen, D.H., Giri, B., Collins, G., and Taub, D.D. (2005) Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. Exp Cell Res 304: 559-569.
34. Ohtani, Y., Irie, T., Uekama, K., Fukunaga, K., and Pitha, J. (1989) Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes. Eur J Biochem 186: 17-22.
35. Parton, R.G., Joggerst, B., and Simons, K. (1994) Regulated internalization of caveolae. J Cell Biol 127: 1199-1215.
36. Pelkmans, L., Kartenbeck, J., and Helenius, A. (2001) Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 3: 473-483.
37. Pelkmans, L., Puntener, D., and Helenius, A. (2002) Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296: 535-539.
38. Persing, D.H., Varmus, H.E., and Ganem, D. (1987) The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid. J Virol 61: 1672-1677.
39. Petersen, J., Dandri, M., Mier, W., Lutgehetmann, M., Volz, T., von Weizsacker, F., et al. (2008) Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol 26: 335-341.
40. Pietiainen, V., Marjomaki, V., Upla, P., Pelkmans, L., Helenius, A., and Hyypia, T. (2004) Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II, and signaling events. Mol Biol Cell 15: 4911-4925.
41. Saldanha, J., Gerlich, W., Lelie, N., Dawson, P., Heermann, K., and Heath, A. (2001) An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 80: 63-71.
42. Schaefer, S. (2007) Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13: 14-21.
43. Schulze, A., Gripon, P., and Urban, S. (2007) Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 46: 1759-1768.
44. Seitz, S., Urban, S., Antoni, C., and Bottcher, B. (2007) Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions. EMBO J 26: 4160-4167.
45. Sun, D., and Nassal, M. (2006) Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus. J Hepatol 45: 636-645.
46. Sun, X., and Whittaker, G.R. (2003) Role for influenza virus envelope cholesterol in virus entry and infection. J Virol 77: 12543-12551.
47. Teissier, E., and Pecheur, E.I. (2007) Lipids as modulators of membrane fusion mediated by viral fusion proteins. Eur Biophys J 36: 887-899.
48. Ugawa, T., Kakuta, H., Moritani, H., Matsuda, K., Ishihara, T., Yamaguchi, M., et al. (2000) YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species. Br J Pharmacol 131: 63-70.
49. Vincent, N., Genin, C., and Malvoisin, E. (2002) Identification of a conserved domain of the HIV-1 transmembrane protein gp41 which interacts with cholesteryl groups. Biochim Biophys Acta 1567: 157-164.
50. Walter, E., Keist, R., Niederost, B., Pult, I., and Blum, H.E. (1996) Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 24: 1-5.
51. Wounderlich, G., and Bruss, V. (1996) Characterization of early hepatitis B virus surface protein oligomers. Arch Virol 141: 1191-1205.
52. Xu, X., and London, E. (2000) The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation. Biochemistry 39: 843-849.
53. Zidovetzki, R., and Levitan, I. (2007) Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategies. Biochim Biophys Acta 1768: 1311-1324.